Products

90% of patients show bone fusion as well as strong clinical improvements in function and pain at 24 months follow-up with a good product safety profile.

The company's FiberCel, ViBone and OsteGro V viable bone matrices address orthopedic and spine applications.

OsseoGEN CBM contains the three elements needed for bone regeneration; osteoconductivity, osteoinductivity and osteogenicity.

NanoBone bone grafting material incorporates nano-crystalline hydroxyapatite particles that are similar in size, chemistry and morphology to HA particles of human bone.

Tornado synthetic and bioactive bone graft alternative is delivered to the surgical site safely and quickly using the GraftMag Graft Delivery System.

DUROLANE injection treats knee osteoarthritis in patients who have failed to respond adequately to conservative non-pharmacological therapy or analgesics.

MagnetOs bone graft, an alternative to autograft, has experienced strong adoption by spinal surgeons since U.S. launch in 2019.

The $2 million grant will fund a Phase I/II clinical trial of HST-003 for regeneration of cartilage in the knee.

The research is investigating amniotic tissue as a potential treatment for chronic musculoskeletal pain and function disorders.

This U.S. Phase II trial intends to demonstrate safety and efficacy of Fibrin-PTH in patients undergoing a single-level TLIF procedure.